On air · 2 of 3 networks
Cradle
- cradle.bio
- Healthcare & Life Sciences
- NL
- 136 employees
Cradle’s ads on LinkedIn, Meta and Google, recorded by adsrunning. Browse the latest here for free. Sign up free to see all 267. Watch Cradle with Starter to get each new one in your feed.
Watchlist with Starter · $49/mo
| Network | Status | Live ads | Nov 2025LinkedIn activity · 52 weeksOct 2026 | Checked | Next step |
|---|---|---|---|---|---|
| Running | 104 | Checked 29 Oct 2026 | See all 267 ads → | ||
| Meta | Not checked | — | |||
| Running | 7 | Ads on the Google Ads Transparency Center | Checked 26 Oct 2026 | Collect them with the API → |
Cradle has 104 live LinkedIn ads. We recorded 7 Google ads on 26 Oct 2026.
Latest ads
- LINKEDIN · IMAGESince 10 Aug 2026
What if you could train your own molecular AI on your local fitness landscape... with a few clicks? Cradle learns from every design and every experiment – including the negative ones – and improves round over round. Learn more about active learning on Cradle: cradle.bio/platform Cradle is the end-to-end Molecular Engineering Platform. Built for scientists.
- LINKEDIN · IMAGESince 10 Aug 2026
One platform, from the first design to the molecule you take forward. Learn more about Cradle: cradle.bio/platform
- LINKEDIN · IMAGESince 10 Aug 2026
Fixing stability and losing affinity is not progress. Molecules rarely fail because they don't bind. They fail on developability, stability, expression, manufacturability, and safety — the properties that decide whether a molecule becomes a product. Cradle lets scientists engineer multiple properties in parallel, in one campaign, so promising molecules stay promising as they move downstream. Every round of experimental feedback sharpens the next set of designs, and that learning stays with you. 10 out of the top 25 biopharma already rely on Cradle for their protein R&D. See how multi-property optimization works in Cradle: cradle.bio/platform Cradle is the end-to-end Molecular Engineering Platform. Built for scientists.
- LINKEDIN · IMAGESince 10 Aug 2026
Finding a binder is a starting line. But a binder isn’t a product. AI has made hit generation faster than it has ever been. But the molecules that fail in development don’t fail because they don’t bind. Cradle takes your molecule from hit ID to candidate, with multi-property optimization and continuous learning built-in. One platform, from the first design to the molecule you take forward. Learn more about Cradle: cradle.bio/platform
- LINKEDIN · IMAGESince 10 Aug 2026
What if every “failed” assay became the reason your next design works? Train Cradle on your molecule's assay data and design, optimize, and advance your molecules. From first design to final molecule. Learn more: https://lnkd.in/e-3Eey3D/?utm_campaign=CG-EU&utm_source=linkedin&utm_medium=paid&utm_id=1002130504&hsa_acc=511570118&hsa_cam=1002130504&hsa_grp=576002664&hsa_ad=1494570864&hsa_net=linkedin&hsa_ver=3
- LINKEDIN · IMAGESince 10 Aug 2026
Stop throwing away your assay data. Cradle learns from every design and every experiment – including the negative ones – and improves round over round. Learn more about active learning on Cradle: cradle.bio/platform Cradle is the end-to-end Molecular Engineering Platform. Built for scientists.
6 of 267 adsSign up to see every Cradle ad, filter by format and date, and get alerts on new ones.
See all 267 adsWatch the companies you care about.
Filter every ad by industry, country, format and network, and get alerts when a company you watch starts running new ads.